High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.

Kouchaki E, Afarini M, Abolhassani J, Mirhosseini N, Bahmani F, Masoud SA, Asemi Z

Open source

DOI
10.1093/jn/nxy116
Published
2018 Aug 1
Container
The Journal of nutrition
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jn/nxy116,
  title = {High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.},
  author = {Kouchaki E and Afarini M and Abolhassani J and Mirhosseini N and Bahmani F and Masoud SA and Asemi Z},
  year = {2018},
  journal = {The Journal of nutrition},
  doi = {10.1093/jn/nxy116},
  url = {https://doi.org/10.1093/jn/nxy116}
}

RIS

TY  - JOUR
TI  - High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.
AU  - Kouchaki E
AU  - Afarini M
AU  - Abolhassani J
AU  - Mirhosseini N
AU  - Bahmani F
AU  - Masoud SA
AU  - Asemi Z
PY  - 2018
JO  - The Journal of nutrition
DO  - 10.1093/jn/nxy116
UR  - https://doi.org/10.1093/jn/nxy116
ER  - 

APA

E, K., M, A., J, A., N, M., F, B., SA, M., & Z, A. (2018). High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.. The Journal of nutrition. https://doi.org/10.1093/jn/nxy116

Source records